Firms

Moore Strategic Ventures

Moore Strategic Ventures is the privately held investment company of Louis Bacon.

Founded
—
Type
Venture capital

Team

No team members on record yet.

Co-investing

Andreessen Horowitz
ARCH Venture Partners
Baillie Gifford
Founders Fund
137 Ventures

Investments

$16M2026-02-23XFlowGeneral Catalyst, PayPal Ventures, Moore Strategic Ventures, Stripe, Lightspeed, Square Peg Capital
$55M2024-01-23ElephasARCH Venture Partners, Tao Capital Partners, Northpond Ventures, Sands Capital, Moore Strategic Ventures
$55M2024-01-23Elephas BiosciencesARCH Venture Partners, Northpond Ventures, SV Health Investors, Sands Capital, Moore Strategic Ventures, AF Ventures
$115M2024Maze TherapeuticsARCH Venture Partners, Casdin Capital, Andreessen Horowitz, Logos Capital, GV, General Catalyst, Moore Strategic Ventures
$73M2023-05-18Myeloid TherapeuticsARCH Venture Partners, 8VC, Alexandria Venture Investments, Moore Strategic Ventures, Primary Venture Partners, Newpath Partners
$270M2023-04-26Orbital TherapeuticsARCH Venture Partners, Casdin Capital, Alexandria Venture Investments, Andreessen Horowitz, Moore Strategic Ventures, Newpath Partners, Vineeta Agarwala
$200M2022-01-18WayveEclipse, Compound, D1 Capital Partners, M12, Lince Capital, Baillie Gifford, Moore Strategic Ventures, Balderton Capital
$355M2022-01-14BoltBlackRock, Schonfeld Strategic Advisors, H.I.G. Growth Partners, Invus Opportunities, CreditEase, Activant Capital, Moore Strategic Ventures, CE Innovation Capital, Digital Horizon
$200M2021-07-13Prime Medicine, Inc.ARCH Venture Partners, F-Prime Capital, GV, Newpath Partners, Casdin Capital, Cormorant Asset Management, Moore Strategic Ventures, PSP Investments, Redmile Group, Samsara BioCapital, T. Rowe Price Associates
$300M2021-05-20WorkriseFounders Fund, Franklin Templeton, 137 Ventures, Andreessen Horowitz, Baillie Gifford, Moore Strategic Ventures